A Single‐Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal Cancer

LESSONS LEARNED. Patients with metastatic colorectal cancer with good performance status or no liver metastasis could benefit from apatinib. Circulating tumor DNA abundance may be a predictor in serial monitoring of tumor load. BACKGROUND. Apatinib, an oral vascular endothelial growth factor (VEGF)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Chen, Xiaofeng, Qiu, Tianzhu, Zhu, Yingwei, Sun, Jing, Li, Ping, Wang, Biao, Lin, Peinan, Cai, Xiaomin, Han, Xiao, Zhao, Fengjiao, Shu, Yongqian, Chang, Lianpeng, Jiang, Hua, Gu, Yanhong
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656475/
https://ncbi.nlm.nih.gov/pubmed/30877190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0164
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados